Wellness
Why gene editors want to treat fetuses when they are still in the womb
![Why gene editors want to treat fetuses when they are still in the womb Why gene editors want to treat fetuses when they are still in the womb](https://i0.wp.com/images.newscientist.com/wp-content/uploads/2024/11/22154005/SEI_229588142.jpg?w=780&resize=780,470&ssl=1)
Genetics liberation can be more effective before birth
Li Barath/my pain
The liberation of CRISPR genes while the embryos in the womb may facilitate the treatment of inherited conditions, especially those that affect tissues such as the heart or muscles.
Kiran Mukonuru at the University of Pennsylvania and his colleagues tested the editing of genes in monkeys, and found that it was more effective at birth. He says, “What we found was amazing.” “It opens the opportunity to treat diseases that it was very difficult to treat after birth.”